Trial Profile
Prediction of the pharmacokinetics of asunaprevir in patients with hepatitis C virus by gadoxetic-acid-enhanced-magnetic resonance imaging
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2019
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 25 Dec 2018 Status changed from not yet recruiting to completed.
- 04 Mar 2015 New trial record